CRISPR基因编辑-AAV
派真生物提供预制的CRIPSR-AAV载体现货，涵盖EFS/miniCMV/CMV广谱启动子和组织特异性启动子，可直接用于动物体内实验，绝大多数均可现货直发，大大地节约客户的项目时间和成本。
CRISPR基因编辑技术是继TALEN、ZFN技术之后的重大突破，通过gRNA指导核酸酶（如Cas9）对目的基因进行特定编辑。CRISPR-Cas9系统的基因编辑效率高，操作简便，可设计性丰富，基于gRNA或Cas9载体构建与使用现已极为便捷，已广泛应用于哺乳动物、植物及其他物种的基因编辑实验，基于AAV载体的CRISPR-Cas9、CRISPR-Cpf1、ABE或CBE技术是目前广泛使用的基因编辑技术，诞生了很多突破性的发现，并在新药研发与临床研究当中展现了极大的应用价值。
以下仅列出以AAV9血清型的基因编辑AAV载体，更多载体定制请咨询派真生物或在本页提交您的需求！
| 编号 |
血清型 |
Cas核酸酶类型 |
滴度、体积 |
| AAV9-A2 |
AAV9 |
EFS.SpCas9 |
≥1E+13 GC/mL， 0.1 mL |
| AAV9-B2 |
EFS.SpCas9HF |
| AAV9-B202 |
miniCMV.SpCas9HF |
| AAV9-C202 |
miniCMV.SaCas9 |
| AAV9-C2 |
CMV.SaCas9 |
| AAV9-D2 |
CMV.SaCas9HF |
| AAV9-G101 |
EFS.AsCpf1 |
| AAV9-H101 |
EFS.LbCpf1 |
| AAV9-G102 |
miniCMV.AsCpf1 |
| AAV9-H102 |
miniCMV.LbCpf1 |
| AAV9-C202* |
EFS.SaCas9 |
| AAV9-C206 |
AAV9 |
Elastase I.SaCas9 |
≥1E+13 GC/mL， 0.1 mL |
| AAV9-C207 |
rInsulin 2.SaCas9 |
| AAV9-C208 |
mInsulin2.SaCas9 |
| AAV9-C209 |
hDesmin.SaCas9 |
| AAV9-C210 |
hSynapsin.SaCas9 |
| AAV9-C212 |
MECP2.SaCas9 |
| AAV9-D2* |
CMV.SaCas9HF |
| AAV9-D202 |
EFS.SaCas9HF |
| AAV9-D206 |
Elastase I.SaCas9HF |
| AAV9-D207 |
rInsulin 2.SaCas9HF |
| AAV9-D208 |
mInsulin2.SaCas9 |
| AAV9-D209 |
hDesmin.SaCas9 |
| AAV9-D210 |
hSynapsin.SaCas9 |
| AAV9-D212 |
MECP2.SaCas9 |
派真生物提供以AAV包装的Cas9和Cpf1载体，可以直接、方便、高效地应用于动物实验，每一款现货产品都提供完整的质检报告。
订购信息
| 货号 |
产品描述 |
价格（￥） |
货期 |
| AAV9-A2-50 |
AAV9 [EFS.SpCas9],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-A2-500 |
AAV9 [EFS.SpCas9],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-B2-50 |
AAV9 [EFS.SpCas9HF],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-B2-500 |
AAV9 [EFS.SpCas9HF],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-B202-50 |
AAV9 [miniCMV.SpCas9HF],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-B202-500 |
AAV9 [miniCMV.SpCas9HF],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-C202-50 |
AAV9 [EFS.SaCas9],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-C202-500 |
AAV9 [EFS.SaCas9],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-C2-50 |
AAV9 [CMV.SaCas9],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-C2-500 |
AAV9 [CMV.SaCas9],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-D2-50 |
AAV9 [CMV.SaCas9HF],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-D2-500 |
AAV9 [CMV.SaCas9HF],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-D202-50 |
AAV9 [EFS.SaCas9HF],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-D202-500 |
AAV9 [EFS.SaCas9HF],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-G101-50 |
AAV9 [EFS.AsCpf1],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-G101-500 |
AAV9 [EFS.AsCpf1],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-H101-50 |
AAV9 [EFS.LbCpf1],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-H101-500 |
AAV9 [EFS.LbCpf1],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-G102-50 |
AAV9 [miniCMV.AsCpf1],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-G102-500 |
AAV9 [miniCMV.AsCpf1],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-H102-50 |
AAV9 [miniCMV.LbCpf1],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-H102-500 |
AAV9 [miniCMV.LbCpf1],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-C201-50 |
AAV9 [TBG.SaCas9],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-C201-500 |
AAV9 [TBG.SaCas9],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-C206-50 |
AAV9 [Elastase I.SaCas9],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-C206-500 |
AAV9 [Elastase I.SaCas9],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-C207-50 |
AAV9 [rInsulin 2.SaCas9]≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-C207-500 |
AAV9 [rInsulin 2.SaCas9]≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-C208-50 |
AAV9 [mInsulin2.SaCas9],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-C208-500 |
AAV9 [mInsulin2.SaCas9],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-C209-50 |
AAV9 [hDesmin.SaCas9],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-C209-500 |
AAV9 [hDesmin.SaCas9],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-C210-50 |
AAV9 [hSynapsin.SaCas9],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-C210-500 |
AAV9 [hSynapsin.SaCas9],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-C212-50 |
AAV9 [MECP2.SaCas9],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-C212-500 |
AAV9 [MECP2.SaCas9],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-D201-50 |
AAV9 [TBG.SaCas9HF],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-D201-500 |
AAV9 [TBG.SaCas9HF],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-D206-50 |
AAV9 [Elastase I.SaCas9HF],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-D206-500 |
AAV9 [Elastase I.SaCas9HF],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-D207-50 |
AAV9 [rInsulin 2.SaCas9HF],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-D207-500 |
AAV9 [rInsulin 2.SaCas9HF],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-D208-50 |
AAV9 [mInsulin2.SaCas9],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-D208-500 |
AAV9 [mInsulin2.SaCas9],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-D209-50 |
AAV9 [hDesmin.SaCas9],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-D209-500 |
AAV9 [hDesmin.SaCas9],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-D210-50 |
AAV9 [hSynapsin.SaCas9],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-D210-500 |
AAV9 [hSynapsin.SaCas9],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
| AAV9-D212-50 |
AAV9 [MECP2.SaCas9],≥1E+13 GC/mL,50ul |
￥1,380 |
24h |
| AAV9-D212-500 |
AAV9 [MECP2.SaCas9],≥1E+13 GC/mL,500ul |
￥10,480 |
24h |
|
